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EFFECTS OF ISCHEMIA AND REPERFUSION ON THE LOCAL REGULATION OF 
OXYGEN CONSUMPTION, TISSUE OXYGENATION AND BLOOD SUPPLY IN RAT 
SKELETAL MUSCLE 
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Director:  Roland N. Pittman, Ph.D. 
Professor 
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In resting muscle, blood flow is regulated to meet the demand for O2 by the tissue.  A modified 
ischemia (I)/reperfusion(R) investigation was systematically run and PISFO2, PaO2, Q and VO2 
were observed.  Twenty-nine spinotrapezius muscles from male Sprague-Dawley rats (284±20 
grams) were surgically exteriorized for intravital microscopy to test a model relating blood flow, 
O2 supply and O2 demand.  The model can aid in the understanding of the regulation of tissue 
PO2.  The interstitial PO2 (PISFO2) and perivascular PO2 (PaO2) measurements were made using 
phosphorescence quenching microscopy (PQM).  O2 consumption (VO2) values were obtained 
with a quasi-continuous, flash-synchronized, pressurized airbag to initiate ischemia and sample 
the rate of O2 change (dPO2/dt).  Centerline red blood cell velocity was measured with an Optical 
Doppler Velocimeter and converted to flow using vessel diameter.  5-, 15-, 30-, 60-, 300- and 
600-second ischemic durations were used to observe changes in PISFO2, Q, and VO2.  A critical 
point was observed following 30 seconds of (I) where dPISFO2/dt during recovery was the fastest 
(4.25±0.72 mmHg/s) and was 1.00±0.16 mmHg/s following 600 seconds.  Flow recovery, dQ/dt, 
peaked to 3.88±0.64 (µl·min-1)/s after 60 seconds of (I) but significantly dropped to 2.83±0.55 
(µl·min-1)/s following 300 seconds of (I) but increased to 2.92±0.45 (µl·min-1)/s following 600 
seconds.  This gives evidence to a no-reflow phenomenon occurring in the extended periods of 
ischemia.  A peak in VO2 to 309.2±45.0 nl O2/cm3·s with a time course of 160 seconds occurred 
following 600 seconds of ischemia.  As the ischemic duration decreased, the time course and 
peak VO2 also decreased.  VO2 following 300 seconds of (I) was significantly higher than 5-60 
seconds of (I) (p <0.05) but was not significantly different from 600 seconds of (I).  The 
information collected during the Q and VO2 studies can be incorporated into a factor, M, that 
relates VO2, Q and ¨PO2.  M calculated for the recovery of 5- through 60-second (I) groups 
reasonably relates the three variables due to consistency and little variability.  However, recovery 
in 600- and especially 300-second (I) groups showed higher variability in M which requires more 
consideration. 
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INTRODUCTION 
 In resting conditions, the flow of oxygen-rich blood is constantly regulated to meet the 
demand for oxygen by respiring tissue and to provide the energy to sustain life through a 
coordinated effort of the cardiovascular and respiratory systems.  In instances such as exercise 
when the demand for oxygen initially exceeds the supply, a normal imbalance begins to occur 
and the organism responds with compensatory changes in ventilation and blood flow.  By cutting 
off blood flow (vascular occlusions or collapse) or decreasing the oxygen-carrying capacity of 
the blood (e.g., traumatic hemorrhage or hemolysis), the prolonged supply and demand 
imbalance and resulting ischemia and hypoxia can cause irrevocable harm to the tissue and 
organism.  The mechanism for the regulation of tissue oxygenation should be able to explain the 
relationship among flow of oxygenated blood, the amount of oxygen supplied to the tissue, and 
the rate at which the tissue consumes it and how changes in any of the three intrinsic 
characteristics are compensated.  Using Fick’s principle the relationship among these three 
variables in the microcirculation can be mathematically modeled. If a model can be established, 
it would simply define what the limits of the change in one parameter are with respect to the 
other two. With this model, any proposed mechanism can be tested and if the results deviate 
from the defined limits, it can be reasoned that it is not the true mechanism or there are 
additional undefined variables at work. An extension of this is that it can also show how a 
pathology of one of the characteristics can affect the other—so long as the affected parameter is 
within the limits originally defined. Ultimately, an understanding of the relationship between the 
supply of and demand for oxygen in the microcirculation can lead us to increase the efficiency of 
maintaining the balance between them. 
 
 2 
Cardiovascular System and Role of Oxygen 
 One of the most important functions of the cardiovascular system is to deliver oxygen to 
respiring cells that make up an organ and use that oxygen to generate ATP.  Since oxygen is a 
non-polar molecule with limited solubility in aqueous solutions such as blood, it is carried in the 
red blood cells bound to hemoglobin.  Hemoglobin A (HbA), the most abundant form of 
hemoglobin in adult humans, is a tetrameric protein with two alpha and beta subunits non-
covalently linked with a heme group attached to each subunit.  Heme groups contain iron held in 
a heterocyclic porphyrin ring and it is at the iron where oxygen binds.  The iron will exist in 
either the 2+ (ferrous) state in which oxygen is able to bind or the 3+ (ferric) state or metHb 
which cannot bind oxygen.  The two conformations of HbA, T(taut) or R(relaxed), determine its 
affinity for oxygen.  In the lungs, where the pH is high and carbon dioxide is low, HbA will be in 
the relaxed form which has a high affinity for oxygen and, in areas where pH is lower and carbon 
dioxide is higher, such as metabolically active tissue during exercise, the T form is preferred and 
the affinity for oxygen decreases, so that it can be released from the hemoglobin and taken up by 
the adjoining tissue. 
 The oxygen which diffuses into cells serves as an electron acceptor within the 
mitochondria to facilitate the formation of adenosine triphosphate (ATP) via oxidative 
phosphorylation.  Due to its high-energy phosphate bonds, releasing anywhere from 30-50 
kilojoules of energy per mole of every phosphate split (Gajewski et al., 1986), ATP serves as the 
preferred energy currency of the cell. 
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Regulation of Blood Flow 
 To maintain a consistent supply of oxygen, the cardiovascular system ensures that the 
process by which they are supplied—the flow of blood—is tightly regulated.  In periods of high 
respiration where the demand for oxygen increases, the perfusion of oxygenated blood to that 
organ increases to ensure adequate supply.  Mechanisms to increase the supply of oxygen 
include:  increased ventilation, increased heart rate and stroke volume, increased sympathetic 
activity and elevated hormones, such as epinephrine, norepinephrine and angiotensin II levels.  
Although these mechanisms will act to increase the overall supply of blood to a tissue at any 
given time, they do not guarantee that the demanding tissues are sufficiently supplied.  Local 
regulation of blood flow, specifically at the level of the microcirculation, is ultimately where the 
amount of blood being supplied to the tissue matters most, as this is the site for nutrient and 
waste exchange.  These mechanisms act independently of global mechanisms to ensure that 
tissues are perfused with a sufficient amount of blood to maintain adequate tissue oxygenation.  
Three examples of local blood flow regulation are:  autoregulation, active (functional) hyperemia 
and reactive hyperemia.  Hyperemia refers to the increased flow of blood in tissues and organs. 
 Autoregulation is the intrinsic ability of an organ or tissue to maintain a constant blood 
flow despite changes in perfusion pressure.  Because flow is the ratio of perfusion pressure to 
vascular resistance, as the perfusion pressure begins to drop—as it does in ischemia—the 
resistance of the vascular network that is perfusing the tissue will drop to maintain the supply 
and prevent an oxygen imbalance.  Autoregulation is prominently exhibited in the cerebral and 
coronary circulations (Carlson et al., 2008) where a continuous high degree of activity requires 
these organs to receive constant nourishment and oxygen supply. 
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 When the cellular metabolism of a tissue increases, it begins to produce vasoactive 
compounds (Segal, 2005) that affect the local circulation (classic metabolic hypothesis of blood 
flow regulation).  Occurring most notably in muscle contraction, functional hyperemia occurs 
when these metabolites interact with the nearby endothelium and vascular smooth muscle (Welsh 
& Segal, 1998) of the resistance vessels to induce vasodilation and increase perfusion.  This 
ensures that, as the tissue increases its activity, a deficit in tissue oxygenation will not be created. 
 Following a brief to tolerably prolonged period of vascular occlusion to a tissue or organ, 
a transient increase in blood flow occurs after flow is restored.  While the vessels are occluded, 
vasoactive metabolites such as adenosine—eventual breakdown product of ATP hydrolysis—
accumulate because the tissue continues to remain active to a decreasing extent without its 
oxygen supply being replenished.  These vasoactive compounds (Wong et al., 2003) will go on 
to interact with smooth muscle and cause it to relax, thereby dilating the resistance vessels, so 
that when perfusion is restored, flow will be elevated above baseline for a period of time.  This 
transient increase in blood flow post-occlusion is what is referred to as reactive hyperemia.  As 
the accumulated metabolites are washed out by the blood, the resistance vessels regain their 
resting vascular tone and the transient elevation of flow subsides with the return to baseline. 
 Two of the most widely accepted hypotheses for mechanisms of the local regulation of 
blood flow have been the metabolic and myogenic hypotheses.  The metabolic hypothesis 
(DeFily & Chilian, 1995) states that the regulation of blood flow is coupled to the metabolic 
activity of the perfused organ or tissue.  When there is an increase in tissue metabolism or a 
hypoxic episode, in which the demand for oxygen exceeds the supply, there is an increase in the 
production of certain vasoactive compounds such as: lactic acid, adenosine and potassium ions 
(Tang et al., 2004).  Carbon dioxide (Duling, 1973), another metabolic product of respiration, 
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also acts as a vasodilator in the same capacity as lactic acid; when both are dissolved in aqueous 
blood, the hydrogen ions that dissociate act to decrease the pH of the blood eliciting a pH-
sensitive central and peripheral chemoreceptor response.  As these compounds accumulate, they 
act to decrease the vascular tone of resistance vessels causing vasodilation. 
 The myogenic hypothesis (Moore et al., 1994), another mechanism to explain local 
control of blood flow, states that the smooth muscle within resistance vessels reacts to stretch, 
causing the muscle to depolarize and contract, leading to vasoconstriction.  When the increased 
stretch subsides, the smooth muscle relaxes, returning blood flow to baseline. 
 Although widely regarded as the standard for explaining metabolically-linked changes in 
blood flow, the metabolic hypothesis hinges on the fact that there are metabolites that are 
produced which cause changes in blood flow.  With more metabolites still being discovered, the 
possibilities become endless which calls into question the idea that one of the metabolites 
identified under this hypothesis could actually be the mediator of a more complete mechanism.  
Functionally, the myogenic hypothesis relates the intraluminal pressure to vascular tone.  Under 
resting conditions, this may be able to explain how blood flow is kept at a baseline level but, 
when it is necessary for the heart rate, contractility and blood pressure to increase, as in exercise, 
the explanation starts to fall apart (Schubert & Mulvany, 1999).  During exercise, the cellular 
metabolism of tissues increases and waste production and the demand for oxygen increases. 
  
 6 
Ischemia/Reperfusion 
 Ischemia is defined as the restriction of blood flow to a tissue or organ, decreasing the 
amount of oxygen and nutrients available to it to continue cellular metabolism (Frank et al., 
2012).  If the blood and oxygen supply is cut off for a prolonged period of time, an ischemic 
cascade is initiated that can extend well past the point where flow returns.  This cascade, as 
expected, is initiated by cells producing lactic acid through anaerobic metabolism and eventually 
ATP production ceases.  A lack of ATP prevents ion pumps from functioning and upon 
depolarization, the calcium that becomes trapped in the cell induces more calcium to enter the 
cell and overload it.  This overload of calcium enhances the generation of reactive oxygen 
species and triggers the opening of the mitochondrial permeability transition pore (Brandao et 
al., 2003).  When cytochrome c is exposed to the cytosolic environment, it dissociates from the 
electron transport chain, binds and activates quiescent pro-apoptotic factors which then induce 
apoptosis, most notably through a caspase response (Brookes et al., 2004).  As the cell breaks 
down, it releases harmful chemicals into the interstitium which can damage and induce apoptosis 
in nearby cells, initiating a chain reaction of damage that continues well beyond the return of 
oxygenated blood flow. 
 A variety of pathologies have been attributed to ischemia, including: myocardial 
infarction, atherosclerosis, embolism and hemorrhage associated with aneurysms.  Restoration of 
oxygenated blood flow is known as reperfusion and often times, after prolonged ischemic 
conditions and the buildup of harmful substances due to tissue necrosis, the washout of the 
chemicals spreads systemically and, because degradation of these active compounds is not 
immediate, they go on to cause inflammation and damage in tissue away from the site of original 
ischemic damage (Szokoly et al., 2006). 
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From Model to Mechanism 
 Despite the various pathologies associated with ischemia/reperfusion injury, modified 
protocols have repeatedly been used to understand the mechanism of tissue oxygenation and 
blood flow regulation.  By inducing an ischemic condition in a vascular bed, changes between 
the supply and demand of oxygen and blood and its regulation can be observed in situ using 
intravital and phosphorescence quenching microscopy.  Although these techniques cannot 
explain the underlying biochemical changes that could be mediating the regulation, they can 
define what the changes should look like if used correctly. 
 For a mechanism of the regulation of tissue oxygenation and blood flow to be complete, 
it should be able to explain how changes in any of the three intrinsic characteristics -- flow of 
oxygenated blood, the amount of oxygen supplied to the tissue and the rate at which the tissue 
consumes it -- are compensated.  In addition to being able to describe the changes that take place, 
the proposed mechanism should be able to explain the relationship among these three variables. 
 Fick's principle, at the level of the whole organism, has been used to describe the 
relationship of oxygen consumption to cardiac output and the arteriovenous oxygen content 
difference.  The principle relies on mass balance with respect to the regulation of tissue 
oxygenation, in other words, the total amount of oxygen that is consumed by the tissue or organ 
( ሶܸைమ ) is equal to the product of the flow of blood through it (ܳ) and the difference in the 
incoming arterial ([ܱଶ]௜௡) and outgoing venous ([ܱଶ]௢௨௧) oxygen concentrations. 
 ሶܸைమ = ܳ ή {[ܱଶ]௜௡െ[ܱଶ]௢௨௧}      Eq. 1 
 Using Fick's principle this study will attempt to describe the relationship among these 
three variables in the microcirculation with a mathematical model.  If a model can be established, 
it would be used to define the limits of the change in one parameter with respect to the other two.  
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With this model, any proposed mechanism can be tested and, if the results deviate from the 
defined limits, it can be reasoned that there are additional undefined variables involved and the 
mechanism would need to be revised. 
 Because of the technical design and limitations, data were collected individually for the 
three parameters and then combined.  Ischemia was induced by using a pressurized airbag over 
to the tissue which was rapidly inflated (<1sec) to 140 mmHg to arrest flow and extrude blood; 
the airbag was then rapidly deflated (<1sec) to 5mmHg to initiate reperfusion.  The oxygen 
tension of the interstitial fluid was measured using phosphorescence quenching microscopy 
(PQM).  Using information from the oxygen dissociation curve, the concentration of 
haemoglobin and its capacity to carry oxygen, oxygen tension values were converted to oxygen 
contents.  Blood flow in a nearby arteriole was measured by converting the centerline RBC 
velocity collected from an Optical Doppler Velocimeter to flow using vessel diameter 
determined simultaneously from video sequence image analysis.  Using perivascular oxygen 
tension measurements collected to represent arteriolar PO2, the flow of oxygen was determined 
by combining the information collected about oxygen contents and blood flow.  Oxygen 
consumption by the tissue was measured by using a quasi-continuous approach (5-sec flow 
stoppage/15-sec flow recovery) to observe dPO2/dt using the PQM and ischemia/reperfusion 
system.  Since it is known that the PQM method itself consumes oxygen, the overestimated 
consumption values collected were corrected for by using a novel 1 Hz/10 Hz correction system. 
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Materials & Methods 
Animals 
Twenty-nine male Sprague-Dawley (SD) rats (Harlan, Indianapolis, IN) with an average weight 
of 284±20 grams were utilized in this study.  The study was approved by the Virginia 
Commonwealth University Institutional Animal Care and Use Committee whose policies are 
consistent with the National Institutes of Health (NIH) Guidelines for the Humane Treatment of 
Laboratory Animals, as well as the American Physiological Society’s Guiding Principles in the 
Care and Use of Animals.  The rodents were maintained on regular laboratory rodent chow and 
housed in the university’s animal facility in accordance with institutional guidelines.  The 
rodents were kept two per plastic cage under a 12hr/12hr light/dark cycle with properly 
maintained ventilation and climate control (20-23 degrees Celsius with humidity at 40-60%) 
under the supervision of the Division of Animal Resources. 
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Anesthesia and Euthanasia 
The rodents were initially anesthetized with an intraperitoneal injection of a mixture of Ketamine 
HCl (75 mg/kg, Bioniche Teoranta, Inverin, Co Galway, Ireland) and Acepromazeine (2.5 
mg/kg, Butler Animal Health Supply, Dublin, OH).  The Ketamine provides the necessary depth 
of anesthesia for surgical procedures until the Alfaxalone infusion can begin.  After the initial 
sedation, the rodent was kept on a continuous intravenous administration of Alfaxan (Alfaxalone 
10 mg/ml, Vetoquinol UK LTD, Buckingham, MK18 1PA, UK) via an infusion pump (SP120p, 
World Precision Instruments Inc, Sarasota, FL) at a rate of 0.35 ml/hr.  Upon completion of the 
experiment and in accordance with non-aseptic non-survival protocols, the anesthetized rodent 
was euthanized with 0.1 ml of Euthasol (Pentobarbital 390 mg/ml and phenytoin 50 mg/ml, 
Delmarva Laboratories Inc, Midlothian, VA). 
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Surgery 
The rodents were weighed and given a lower-left quadrant intraperitoneal injection of Ketamine 
and Acepromazine.  Upon verification of sufficient sedation using the heel-pinch technique, the 
rodent was transferred to a thermostabilized mat set at 37 ºC for surgical preparation.  Three 
locations were made available for use by using an electric shaver and a depilatory cream such as 
Nair (Church and Dwight Inc, Princeton, NJ):  the dorsal area extending from the shoulder blade 
to the base of the ribcage so as to exteriorize the spinotrapezius muscle for optical microscopy, 
the skin between the mouth and clavicle for the tracheostomy, and the right ventral thigh for 
continuous anesthetic infusion and euthanizing agent via the femoral vein.  The sites were wiped 
clean with isopropyl alcohol (BD, Franklin Lakes, NJ). 
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Figure 1.  Ventral view of shaved regions for tracheostomy and venular cannulations. 
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Figure 2.  Dorsal view of shaved region for spinotrapezius exteriorization. 
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Femoral Vein Cannulation 
A 5 mL syringe of Alfaxan was attached to a three-way stopcock with a 10 mL syringe of 20 
unit/mL heparinized saline (Baxter Pharmaceutical, Deerfield, IL) with a 10 in?? PE-50 
(Polyethylene tubing, Clay Adams, Parsippany, NJ) luer-locked tube that would serve as the 
cannula for continuous anesthesia infusion.  The heparinized syringe would serve to disintegrate 
clots that might form within the cannula, although because of continuous infusion, clot formation 
would be highly unlikely.  The rodent was rotated while in the supine position so that the head 
was facing furthest away from the surgeon.  Using scotch tape, the left hind limb was stretched 
by securing one end of the tape to the foot and the other to the bench top.  At the location where 
the hind limb extends from the abdomen, an approximately 1 cm incision was made in the 
integument with blunt dissection scissors that extended the opening and separated the skin from 
the underlying superficial fascia.  Once the cleft between the abdominal and leg muscles were 
visible, the branches of the femoral vessels could be seen running down the leg.  The fascia was 
separated with blunt dissection scissors placed between the muscles moving toward the vertebral 
column.  Taking note of the vessel bifurcation locations, the cannulations occurred proximal to 
the major bifurcation.  The femoral artery, vein, and nerve are bundled together in the fascia so 
the first step was to separate the vessels and nerve from each other using curved, blunt forceps.  
Ensuring there was enough light and that the area was sufficiently moisturized with phosphate 
buffered saline (PBS, Sigma), the separation was performed under a stereomicroscope (Nikon 
SMZ645, Melville, NY) and the vein was tweezed apart.  With two 12.5 cm hemostats, a 4 inch 
distal suture was securely looped around the vessel to prevent blood flow from the leg to the 
heart.  The proximal suture was loosely looped and, using the hemostats, the vessel was pulled so 
as to provide tension on the vessel and prevent any backflow of blood.  Using microdissection 
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scissors (Vannas, 3mm straight), a ¼ circumferential incision of the vein was made and the 
cannula was inserted.  Successful cannulation was confirmed when a small quantity of blood was 
able to be withdrawn; then the Alfaxan syringe was immediately connected to the infusion pump.  
The incision site was sealed with a small piece of scotch tape so as to prevent desiccation. 
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Figure 3.  Femoral vein cannulation for continuous anesthesia infusion. 
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Tracheostomy 
Tracheal intubation allows for the maintenance of a patent airway, ensuring normal blood gas 
and acid-base balances (PO2 ~ 85-95 mmHg, SO2 ~ 90-95%, PCO2 ~ 40 mmHg, pH ~ 7.4) while 
under anesthesia.  Immediately after the femoral vein cannulation, while ensuring the animal was 
sufficiently anesthetized and placed ventral side up on the thermostabilized heating pad, with the 
head toward the surgeon, a lateral cut (~1 cm) of the skin was made with blunt dissection 
scissors perpendicular to the body axis, approximately 1.5 cm below the mouth, even with the 
jawline of the rodent.  The opening was widened until the skin was separated from the 
underlying connective and fat tissue.  A thick, tough connective/fatty tissue layer (superficial 
fascia) was visible and cleared away between the mandibular glands in order to expose the 
underlying sternohyoid muscle.  Two forceps were used to divide the muscle down along the 
body axis and, using the same forceps, the trachea was isolated by hooking under the elevated 
trachea.  With the trachea elevated using one of the curved forceps, a piece of 3-0 non-sterile, 
braided silk (Fine Science Tools - FST, Foster City, CA) was threaded under the forceps and 
pulled with a hemostat to provide slight tension on the trachea for incision and cannulation.  A 
1/3 circumferential incision was made with the microdissection scissors between the bands of 
cartilage and 1 cm of a 3-cm PE-240 tracheal cannula was immediately placed into the airway 
and tied off with the threaded suture. 
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Figure 4.  Ventral view of tracheostomy site for patent airway maintenance. 
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Spinotrapezius Muscle Preparation 
For the purposes of this work, the use of intravital microscopy techniques required the surgical 
exteriorization of the rat spinotrapezius muscle (Gray, 1973 and Bailey et al, 2000).  After 
placing the animal in the prone position, a dorsal midline incision was made from the lumbar to 
the cervical region, exposing the underlying superficial fascia.  A perpendicular incision of the 
integument was made on both ends of the initial dorsal incision to create a skin flap.  Using a 
low-temperature cautery device (Bovie, Bovie Medical, Clearwater, FL), bleeding originating 
from the surrounding connective tissue and skin was cauterized.  The fascia that covers the tissue 
was removed so that the muscle and the thin strap muscle on the left lateral border running 
parallel to the spinotrapezius were exposed but not damaged.  A pair of curved scissors was used 
to separate the spinotrapezius muscle from the underlying muscle layers starting at the left lateral 
border toward the muscle insertion point on the scapular spine and continuing towards the distal 
end of the thoracolumbar origin.  6-0 silk thread was sutured every 1 cm along the strap muscle 
as the muscle was separated to ensure minimal trauma to the spinotrapezius.  The right lateral 
border was excised from the vertebral axis using the cautery to liberate the muscle from its 
scapular attachment and was similarly sutured.  The tissue was kept moist with frequent 
applications of PBS.  Once the spinotrapezius was successfully isolated and the attachment 
points set, the animal was placed onto a thermostatic animal platform (Golub and Pittman, 2003) 
with the muscle held in place with sutures at the attachment points on the platform (see Figure 
5).  The muscle was blotted with 41 grade filter paper (Whatman) to remove any excess fluid and 
R0 probe was immediately applied to the area to be studied.  Another piece of filter paper was 
placed over the muscle and the entire preparation was covered with a 12 micron thick gas barrier 
polyvinylidene chloride film (Krehalon, Japan) to prevent desiccation.  The tissue was loaded 
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with R0 probe by incubating it for approximately 45 minutes after which the filter paper was 
removed and the Krehalon film was affixed back to the preparation, ensuring that all air bubbles 
had been removed with the push of a cotton swab, being careful not to damage the preparation. 
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Figure 5.  Right dorso-lateral view of spinotrapezius exteriorization and attachment to 
thermostatic animal platform for intravital microscopy. 
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Stop-flow Device to Induce Ischemia/Reperfusion 
The stop-flow device (Golub et al., 2011a) was used to rapidly stop blood flow and extrude 
blood from most of the vessels in the spinotrapezius muscle preparation when inflated and 
restore blood flow when deflated.  In its construction, a rubber grommet was placed around the 
front lens enclosure of a 20x/0.45 objective (Zeiss, Thornwood, NY).  The grommet was pierced 
by an 18-gauge blunted needle which was connected to a pressure regulator.  Krehalon film was 
wrapped around the grommet loosely enough to leave an air pocket, so that the film was spaced 
from the lens and could be quickly inflated to stop flow.  A rubber O-ring was fastened around 
the Krehalon film and grommet and the preparation was secured with electrical tape to prevent 
leakage of air.  The sealed device was connected to a flash-synchronized, Automatic Dual 
Pressure cycler to quickly switch between high and low pressures.  Depending on what was to be 
observed, the cycler was switched to either synchronize the excitation flash of the PQM system 
so that data were recorded only when the bag was inflated (specifically during the oxygen 
consumption study) or to inflate the air-bag independently of the flash.  To minimize oxygen 
inflow while the study was being performed, the bag was inflated to a basal 5 mmHg and, to 
decrease the amount of friction between the two film pieces in contact, a small drop of a water-
based lubricant (KY brand) was added between the two film pieces to allow easy movement 
when changing measurement sites.  The bag was inflated to 140 mmHg within <1sec to rapidly 
stop blood flow and initiate ischemia and was deflated back to 5 mmHg to restore blood flow, 
also within <1sec. 
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Figure 6.  Components of the air- bag unit (from left to right):  Krehalon film, 20x/0.45 
objective, grommet, blunt needle, O-ring, electrical tape. 
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Figure 7.  Flash-synchronized Automatic Pressure Cycler. 
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Figure 8.  Completed stop-flow device on microscope. 
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Phosphorescence Quenching Microscopy 
The method of phosphorescence quenching microscopy consisted of an Axioplan 2 intravital 
microscope (Zeiss, Germany) constructed with other optical equipment on an optical breadboard 
(Edmund Optics, Barrington, NJ).  To observe changes in arteriolar diameter, the microscope 
was equipped with a video camera (MTI CCD72, Dage-MTI, Michigan City, IN) and a 
customized photomultiplier unit to register the phosphorescence signal.  The phosphorescence 
signal was gathered by an Achroplan 20x/0.45 objective (Zeiss, Germany) and sent to an analog-
to-digital converter (SCB-68, National Instruments, Austin, TX) to be analyzed with custom 
software written in LabVIEW (National Instruments, Austin, TX).  To limit the contribution of 
oxygen inflow to the interstitial PO2 within the illuminated tissue disc, a flash area of 600 µm 
was used.  Perivascular PO2 measurements were also taken to represent the arteriolar PO2, a 
technique that previous data (Golub et al., 2011b) had shown to support.  The flash area was 
decreased to 65 µm and oriented to the center of the vessel to limit the contribution of oxygen 
inflow from the adjacent interstitium and ensure that the phosphorescence signal came only from 
the region encompassed by the arteriole.  In both cases of oxygen tension measurements, a xenon 
flash lamp (FX-249, PerkinElmer, Salem MA) was used to excite the area with an output of 167 
mJ/µs at a rate of 1 Hz and 3 µs flash duration.  Phosphorescence decay curves (500 data points 
per curve) were sampled at a rate of 500 kHz and were analyzed by fitting curves nonlinearly 
with the following rectangular PO2 distribution model (Golub et al., 1997): 
 I(t) = I(0) exp [ - ( K0 + KqM ) t ]·sinh( Kqį t ) / (Kqį t ) + A exp (-t / T ) + B Eq. 2 
where t (ȝs) is the time of phosphorescence decay, I(t) (V) is the magnitude of the 
phosphorescence signal, I(0) (V) is the magnitude of the phosphorescence signal at t = 0, M 
(mmHg) is the mean PO2, į (mmHg) is the half-width of the PO2 distribution, T (ȝs) is the 
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lifetime of the fast post-excitation transient, and B (V) is the baseline offset.  k0, the 
phosphorescence decay rate in the absence of oxygen, and kq, the quenching coefficient for the 
oxygen probe used in this study were 18.3·10-4ȝs-1 and 3.06·10-4 ȝs-1 mmHg-1, respectively 
(Zheng et al., 1996).  All experiments were performed in a dark room. 
 
Pd-MTCPP O2 Probe Preparation and Administration: 
The oxygen-sensitive phosphorescent probe, palladium meso-tetra-(4-carboxyphenyl)-porphyrin 
(Pd-MTCPP, Oxygen Enterprises, Philadelphia, PA), was bound to bovine serum albumin 
(Vanderkooi et al., 1987).  A topical application of the probe solution was given to the surface of 
the spinotrapezius muscle for 45 minutes using 41 grade filter paper (Whatman).  The method of 
application chosen provided sufficient penetration of the probe through the interstitial fluid 
throughout the tissue and prevented intravascular and intracellular penetration (Golub et al., 
2007).  
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Oxygen Consumption Measurements 
PO2 in the interstitium is a function of both oxygen inflow and oxygen consumption.  In normal, 
resting tissue, there is a balance between these parameters brought about by various regulatory 
systems such that the interstitial PO2 (PISFO2) represents the balance between the oxygen supply 
from the incoming arterioles and the oxygen consumption of the respiring tissue.  When an 
imbalance occurs in this sort of equilibrium, a shift in the interstitial PO2 will occur and by 
temporarily eliminating the supply of oxygen (e.g., occlusion of blood supply), the rate at which 
the interstitial PO2 falls becomes a function of the consumption of oxygen by the tissue and the 
methodology .  By correcting for the consumption by the PQM method using alternating 
excitation frequencies coupled with flow arrest (Golub & Pittman, 2008), the rate at which the 
tissue consumes oxygen over a given period of time can be determined (denoted by Vሶ୓మ).   
The interstitial PO2 measured within the illuminated excitation disk formed by the 
phosphorescence quenching system is determined by three variables:  the tissue oxygen 
consumption,Vሶ୓మ; the oxygen consumption by the method itself; and the diffusive supply of 
oxygen from the tissue surrounding the disk.  Utilizing the stop-flow device, the rate at which the 
PO2 falls within five seconds can be ascribed to the rate at which the tissue is consuming oxygen, 
as the inflow of oxygenated blood has been halted.  The following equation describes this (Golub 
et al., 2010): 
 ௗ௉೙
ௗ௡
ൌ െ ௡ܸ െܭ ௡ܲ + ܼ(݌௡ െ ௡ܲ) Eq. 3  
where P୬is the PO2 after the nth flash and ୢ୔౤ୢ୬  is the rate at which oxygen disappears after the nth 
flash.  K is the consumption of oxygen by the methodology and Z is the coefficient that describes 
the driving force of the inflow of oxygen to the flashed region by passive diffusion from the 
surrounding volume.  As the radius of excitation increases, the contribution of passive diffusion 
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of oxygen decreases and, because an octagonal area of excitation of 254558.44 Ɋmଶ was utilized, 
Z was made to be significantly smaller than K so that its impact is negligible in the calculation of 
ୢ୔౤
ୢ୬
 and can be set to be zero.  V୬ is the amount of oxygen consumed by the tissue for the nth 
flash.  Due to the insignificant contribution of Z, the equation can be simplified to describe the 
initial rate at which oxygen is consumed: 
 ଴ܸ ൌ െ
ௗ௉೙
ௗ௡
െܭ ௡ܲ Eq. 4 
The rate at which oxygen is consumed can now be attributed to the rate at which the tissue 
consumes oxygen and the consumption by the methodology.  Once KP୬ is compensated for, the 
equation can be further simplified to measure the rate at which the tissue consumes oxygen: 
 ሶܸைమ = ଴ܸܨߙ Eq. 5 
where F is the rate which the phosphor is being excited and Ƚ  is the solubility of oxygen within 
skeletal muscle (Mahler et al., 1985).  By reinserting the rate at which oxygen is consumed by 
both the tissue and the method, a complete equation that describes the rate at which the tissue 
consumes oxygen can be made: 
 ሶܸைమ = ቀെ ௗ௉೙ௗ௡ െܭ ௡ܲቁܨߙ Eq. 6 
By utilizing a quasi-continuous method for determining the rate of tissue oxygen consumption 
that consists of 5 seconds of bag inflation and 15 seconds of deflation, the time course at which 
the Vሶ୓మ changes following an ischemia period can be determined, in addition to the rate at which 
the tissue is consuming oxygen at the beginning of an ischemic period.  An example of this 
methodology is shown in Figures 9 and 10. 
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Figure 9.  Example PO2/VO2 graph, 30 seconds of ischemia and 200 seconds of reperfusion. 
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Figure 10.  Example PO2/VO2 graph, 10 minutes of ischemia and 15 minutes of reperfusion. 
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Flow measurements 
The flow (Q) of red blood cells is important for the oxygenation of tissue.  In a vessel, it is 
typically calculated as the product of average red cell velocity and the cross-sectional area of the 
vessel, as described by the following: 
 ܳ = ௔ܸ௩௚ ή ܥܵܣ௩௘௦௦௘௟  Eq. 7 
The flow through a vessel of radius, R, can be calculated as the integral of the product of the 
velocity at a certain radius, r, and the cross sectional area over the entire radius of the lumen: 
 ܳ = ׬ܳ௥௜௡௚ = ׬ ݒ(ݎ)2ߨݎ݀ݎோ଴  Eq. 8 
Assuming that red cell velocities have a parabolic Poiseuille dependence, the equation for v(r) 
that describes this can be obtained with the bluntness factor, B, that characterizes the velocity 
profile in the circular lumen (Pittman & Ellsworth, 1986): 
 ݒ(ݎ) = ݒ଴ ቂͳ െ ܤ ቀ௥మோమቁቃ Eq. 9 
where v0 is the velocity along the central line.  Combining v(r) and the volumetric flow rate 
integral to determine the average velocity over the lumen, we get: 
 ௔ܸ௩௚ = ׬ ௩బ൤ଵି஻൬ೝమೃమ൰൨ଶగ௥ௗ௥ೃబ గோమ = ݒ଴ ቀͳ െ ஻ଶቁ Eq. 10 
Through the use of an Optical Doppler Velocimeter (ODV, Borders & Granger, 1984), the 
central velocity along the long axis of the vessel as recorded by the system (VODV) is typically 
converted to Vavg by using the Baker-Wayland velocity conversion ratio, k, of 1.6 (Baker & 
Wayland, 1974) and was confirmed by Davis (1987): 
 ௔ܸ௩௚ = ௏ೀವೇ௞ = ௏ೀವೇଵ.଺  Eq. 11 
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The conversion ratio however does not take into consideration the shape of the velocity profile 
and its dependence on the velocity within the vessel, the diameter of the measured vessel, and the 
hematocrit within the vessel (Pittman & Ellsworth, 1986).  By utilizing a streak length method, 
Al-Khazraji et al (2012) were able to characterize the velocity conversion ratio as a function of 
the vessel diameter: 
 ௏ೀವೇ
௏ೌ ೡ೒
= 0.0071 ή ݀݅ܽ݉݁ݐ݁ݎ+ 1.15 Eq. 12 
By combining this equation with the average velocity over the lumen, we can determine how the 
bluntness profile will look as a function of the vessel radius: 
 ܤ = ଴.଴ଵସଶ௥ା଴.ଵହ
଴.଴଴଻ଵ௥ା଴.ହ଻ହ Eq. 13 
Taking VODV(0) as the velocity given by the ODV and substituting this into the Baker-Wayland 
model, a more generalized case of velocity measured with a finite sensor width (w) and bluntness 
profile along the centerline, the predicted value for VODV is: 
 ைܸ஽௏(0) = ே(଴,௪,஻)஽(଴,௪,஻) Eq. 14 
where 
 ܰ(0,ݓ,ܤ) = ݒ଴ଶ ή 2
ۏ
ێ
ێ
ێ
ۍ ቀ
ଵ
ଶ
ߣ(ͳ െ ߣଶ)ଵ ଶൗ + ଵ
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 Eq. 15 
 ܦ(0,ݓ,ܤ) = ݒ଴ ή 2 ቎ ቀଵଶ ߣ(ͳ െ ߣଶ)ଵ ଶൗ + ଵଶ sinିଵ ߣቁ+
ܤ ቀ
ଵ
଺
ߣ(1 െ ߣଶ)ଷ ଶൗ െ ଵ
ସ
ߣ(ͳ െ ߣଶ)ଵ ଶൗ െ ଵ
ସ
sinିଵ ߣቁ቏ Eq. 16 
and ɉ  is the is the ratio of the fixed sensor width to the luminal diameter.  By calculating the 
ratio of VODV and Vavg as a function of radius, the following equation is obtained for the 
conversion factor, k: 
 ݇ = 0.00604ݎ+ 0.82705 Eq. 17 
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A more accurate determination of the average velocity and flow in a given vessel can now be 
made that corresponds to the velocity profile for vessels of diameter between 37 and 120 
microns. 
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Compartmental Model of Q, VO2 and PISFO2    
The regulation of tissue oxygenation is extremely important for cells in a tissue.  The demand for 
oxygen must be met with a sufficient supply, otherwise an imbalance occurs in one direction or 
the other.  Using Fick’s principle, the matching of oxygen supply and demand to the tissue 
oxygen consumption can be made (Pittman, 2011): 
 ሶܸைమ = ܳ ή {[ܱଶ]௜௡െ[ܱଶ]௢௨௧} Eq. 17  
where Vሶ୓మ is the oxygen consumption/demand by the tissue, Q is the incoming flow, [Oଶ]୧୬ is 
the concentration of oxygen that is coming into the vessel while  [Oଶ]୭୳୲ is the concentration of 
oxygen that is leaving the vessel.  This equation can be rearranged to show oxygen consumption 
as a function of the fraction of oxygen extracted from the incoming flow of oxygen: 
 ሶܸைమ = ܳ ή [ܱଶ]௜௡ ή ቀ[ைమ]೔೙ି[ைమ]೚ೠ೟[ைమ]೔೙ ቁ Eq. 18 
Consider a cylindrical blood vessel of length, L, that has flow, Q, and supplies oxygen to a 
nearby cylindrical sleeve of oxygen-consuming tissue (similar to the Krogh-cylinder model).  
The blood vessel and tissue are separated by interstitial fluid (ISF) that has a uniform partial 
pressure of oxygen.  By equating the difference in convective flow of oxygen to the rate at which 
oxygen diffuses between the blood and the ISF, we get: 
 ܳ{[ܱଶ(ݔ + ݀ݔ)ሿ െ [ܱଶ(ݔ)]} ൌ െߙܦ ቀଶగோο௫ ቁ ൫ ைܲమ(ݔ)െ ூܲௌிܱଶ൯݀ݔ Eq. 19 
where Ƚ is the solubility of oxygen in the tissue, ଶ஠ୖ
ο୶
 is the surface area per unit length of vessel 
divided by the vessel wall thickness which can otherwise be denoted as ɀ , and D is the 
coefficient of diffusion for oxygen at any position x along the vessel and the interstitial fluid.  
The concentration of oxygen within the “linear” portion of the oxygen dissociation curve can be 
expressed as: 
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 [ܱଶ] = ߚᇱ[ܪܾ]ܥு௕ ைܲమ  Eq. 20 
where Ⱦ' is the slope of the “linear” region of the oxygen dissociation curve, [Hb] is the 
concentration of hemoglobin within the blood, and Cୌୠ is the oxygen-binding capacity of 
hemoglobin.  By substituting this back into the previous relationship with ߚ=ߚᇱܥு௕, we get: 
 ܳߚ[ܪܾ]൛ ைܲమ(ݔ + ݀ݔ)െ ைܲమ(ݔ)ൟ ൌ െߙܦߛ൫ ைܲమ(ݔ)െ ூܲௌிܱଶ൯݀ݔ Eq. 21 
Rearranging this equation using the definition of the first derivative, we get the derivative of P୓మ 
which is defined as: 
 
ௗ௉ೀమ
ௗ௫
ൌ െቀ
ఈ஽ఊ
ொఉ[ு௕]ቁ ൫ ைܲమ(ݔ)െ ூܲௌிܱଶ൯ Eq. 22 
Rearranging this so it can be solved as a differential equation gives: 
 
ௗ௉ೀమ
൫௉ೀమ(௫)ି௉಺ೄಷைమ൯ ൌ െቀ ఈ஽ఊொఉ[ு௕]ቁ݀ݔ Eq. 23 
By integrating both sides with respect to the point at which blood enters vessel (x=0) to the point 
at which the blood exits the vessel (x=L), we get: 
 ݈݊ ൬
௉ೀమ(௫)ି௉಺ೄಷைమ
௉ೀమ(଴)ି௉಺ೄಷைమ൰ ൌ െቀ ఈ஽ఊொఉ[ு௕]ቁݔ Eq. 24 
To make x dimensionless, the right side can be multiplied by L/L, turning ߛ = ଶగோ
ο௫
 to Ȟ = ଶగோ௅
ο௫
 
and we end up with: 
 ݈݊ ൬
௉ೀమ(௫)ି௉಺ೄಷைమ
௉ೀమ(଴)ି௉಺ೄಷைమ൰ ൌ െቀ ఈ஽୻ொఉ[ு௕]ቁ ௫௅ Eq. 25 
The PO2 as it is leaving the vessel (at x=L) can now be calculated as: 
 ைܲమ(ܮ) = ூܲௌிܱଶ + ൛ ைܲమ(0)െ ூܲௌிܱଶൟ݁ିቀ ഀವ౳ೂഁ[ಹ್]ቁ Eq. 26 
For all subsequent calculations, ቀ ఈ஽୻
ொఉ[ு௕]ቁ can be called z.  Substituting this as well as [ܱଶ] =
ߚᇱ[ܪܾ]ܥு௕ ைܲమ = ߚ[ܪܾ] ைܲమ back into Fick’s equation for oxygen consumption, ሶܸைమbecomes: 
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 ሶܸைమ = ܳ ή ߚ[ܪܾ] ή ൛ ைܲమ(0) െ ைܲమ(ܮ)ൟ = ܳ ή ߚ[ܪܾ] ή (ͳ െ ݁ି௭)ൣ ைܲమ(0)െ ூܲௌிܱଶ൧ Eq. 27 
By rearranging this equation to solve for ூܲௌிைమ, we get: 
 ூܲௌிܱଶ = ைܲమ(0) െ ௏ሶೀమொήఉ[ு௕]ή(ଵି௘ష೥) Eq. 28 
Eq. 28 can be rearranged in order to group ைܲమ(0) and ூܲௌிܱଶ as ο ைܲమ to get: 
 ߚ[ܪܾ] ή (ͳ െ ݁ି௭) = ௏ሶೀమ
ொήο௉ೀమ
 Eq. 29 
Under steady-state conditions, ߚ[ܪܾ] ή (ͳ െ ݁ି௭) should remain relatively constant and as such, 
can be defined as M. 
 ܯ = ௏ሶೀమ
ொήο௉ೀమ
   Eq. 30 
Since the VO2 and Q data were acquired separately, the average values, including ο ைܲమ, 
computed for the baseline of that corresponding ischemic duration were used.  M can be 
computed to observe the consistency of its behavior—allowing a determination to be made of 
how a model can be ultimately fit. 
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Ischemia/Reperfusion Experimental Protocol 
Ischemia/Reperfusion 
To understand the regulatory mechanisms of blood flow and tissue oxygenation, ischemia was 
induced to by using a flash-synchronized, Automatic Dual Cycler that was attached to a 
pressurized airbag.  The airbag rapidly inflated (<1 sec) to 140 mmHg over the tissue to initiate 
flow arrest and then rapidly deflated (<1 sec) to 5 mmHg to initiate reperfusion.  Because of 
technical limitations, the three phases of the experiments were performed separately and, using 
information that was common to all three, the data were combined to be incorporated into the 
compartmental model.  Well perfused sites were chosen that had an active capillary network and 
one arteriole running parallel with a preferred diameter between 40 and 90 µm. 
 
PISFO2 study: 
Using the method of PQM, oxygen measurements were made in the interstitial fluid in a disk 
region of diameter 600 µm.  The O2-sensitive probe was topically loaded for a period of no more 
than 45 minutes at which point the experiment began once the six sites were chosen.  Data were 
recorded and analyzed with a sampling frequency of 1Hz using the methodology described under 
Phosphorescence Quenching Microscopy. 
 
Q study: 
The centerline red blood cell velocity was measured using an Optical Doppler Velocimeter 
(VODV) and, using the conversion factor that was calculated as a function of the vessel diameter, 
the velocity was converted to average flow.  The data were recorded using a Biopac system at a 
sampling frequency of 1Hz to correspond with the sampling rate of the PQM system.  
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Perivascular baseline PO2 measurements were also sampled with the PQM system by switching 
to an excitation disk region of diameter 65 µm 
 
VO2 study: 
By incorporating the Automatic Dual Cycler system programmed to switch between 5 seconds of 
inflation and flow stoppage of 15 seconds of deflation and recovery, a quasi-continuous method 
was used to observe dPO2/dt.  By incorporating the same PQM methodology, VO2 was sampled 
every twenty seconds in the same disc region but, because of the 5 sec/15 sec limitation, 
baselines during the start of the experimental protocol were extended to get a minimum of three 
measurements.  Due to the same limitation, reperfusion time was also extended to obtain at least 
three measurements.  Based on the data collected during the PISFO2 study, VO2 sampling during 
the recovery began once the PISFO2 > 20 mmHg so that the non-linear region during the very 
early part of reperfusion was avoided.  Perivascular PO2 values during baseline were also 
collected during the oxygen consumption study. 
 
Protocol 
Baseline values were collected for thirty seconds and in the case of VO2, for sixty seconds; 
ischemia was initiated immediately.  Ischemic durations of 5, 15, 30, 60, 300, and 600 seconds 
were chosen to sufficiently capture transient changes of the time course as a function of the 
ischemic duration during reperfusion.  Reperfusion started immediately after the end of ischemia 
with data collected for each group at each site for about three times as long as the ischemic 
duration or 15-900 seconds. This ensured that any changes in the rate at which the tissue 
recovered could be observed.  So that an experiment could be completed within a reasonable 
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amount of time and the risk of any anesthesia-related complications could be discounted, the 5 to 
60 second and 300 to 600 second ischemic durations were done in separate animals.  Within each 
experiment, because of the inherent heterogeneity of the tissue, site-to-site variation was 
accounted for by taking measurements at 3 locations for the shorter durations and 2 locations for 
the longer durations per animal per study.  Baseline PISFO2 data was collected during each study 
as a reference for comparison between the time courses of PISFO2, Q and VO2. 
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Statistical Methods 
Data are presented as mean ± standard error (SEM) unless otherwise specified.  ANOVA and 
Tukey-Kramer’s Multiple Comparison tests were conducted to assess statistical significance 
among the baseline values collected from different ischemic durations.  Two-sample Student’s t-
test was used to determine the significance among the baseline, the initial reperfusion phase, and 
the new steady-state established with respect to the baseline.  It was also used to determine the 
significance of the relating constant, M, between the VO2 and Q studies.  All statistical 
calculations were made using Origin 7.0 and statistical significance was assigned if p <0.05. 
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Results 
Although each study in this project is independent of the others, the results will be 
presented in the order in which they were conducted and analyzed in each ischemic group.  PQM 
was used to measure the oxygen tension in the interstitial fluid of vascular beds during the 
transient PISFO2 study, the oxygen consumption study and the baseline of the flow study.  This 
was done in conjunction with the pressurized stop-flow device for the designated ischemic and 
reperfusion durations as outlined in the protocol section.  Perivascular PO2 measurements were 
taken during the flow and oxygen consumption studies as this was used for the analysis of the 
factor designated, M.  To show how one variable changed in relation to the other two, the data 
were normalized to the baseline and averaged over sites.  This also compensated for the inherent 
site-to-site and animal-to-animal heterogeneity of the microcirculatory variables in the 
spinotrapezius muscle tissue from.  Plots of the averages of the data collected are also presented. 
To determine how the tissue responded to the I/R protocol, measurements were taken at 
one vascular bed (site) per animal for the first nine animals and three for the remaining two for 5- 
and 60-seconds of ischemia.  For the 15- and 30-second groups, one site for the first ten animals 
and three for the remaining two were chosen.  For 300-second ischemia group, one site was 
chosen for six animals and two sites for each of the remaining two animals.  For the 600-second 
ischemia group, one site was chosen for five animals and two for each of the remaining two.  
After observing how the tissue responded by taking one measurement per site for multiple 
durations, three sites were chosen per animal for the 5 to 60 second groups and 2 sites per animal 
for 300 to 600-second ischemia groups.  Sample size information given throughout the 
presentation describes the number of sites observed in that particular phase of the study. 
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The number of sites chosen per animal during the transient study was used thereafter for 
the flow and oxygen consumption studies.  For the flow studies, sites were chosen that had well 
perfused vascular beds with a single arteriole between 50 to 100 µm inside diameter.  The 
baseline PISFO2’s were taken for the vascular bed.  The average arteriole in the study was 
80.0±12.4 (SEM) µm diameter.  Video sequence analysis was used to determine the diameter 
changes as the velocity measurements were taken.  The VODV was converted to flow using vessel 
diameter information as outlined in the Methodology section. 
Since oxygen consumption measurements could only be taken once every twenty 
seconds, to get an accurate baseline established and observe changes post-ischemia, the baseline 
was extended to 60 seconds to get three measurements and the reperfusion times were extended 
to get a minimum of three measurements.  The correction factor, k, was determined to be 
3.5·10-3 s-1 and used to compensate for consumption by the method (see Methods section).  The 
presentation of the VO2 data was truncated to 870 sec since the analysis process determined that 
VO2 did not change once it reached baseline post-ischemia for the duration of reperfusion. 
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5-second Ischemia 
Transient PISFO2 study 
The average data described in Fig. 11 demonstrates that following five seconds of ischemia, the 
oxygen tension went from an average baseline of 65.8±4.2 mmHg to 75% (Fig. 12) or 49.1±3.0 
mmHg before returning to baseline within 15 seconds. 
 
Flow study 
The average data described in Figs. 13 and 14 demonstrate that, following five seconds of flow 
stoppage, the blood flow returned to a baseline of 6.00±0.74 µl/min within three seconds. 
 
VO2 study 
Since the method by which the oxygen consumption measurements were taken was the same as 
the duration of this protocol, it was expected that the oxygen consumption would not vary greatly 
from the baseline.  Figure 15 shows that the oxygen consumption values never varied by more 
than 4% (Fig. 16) of an average baseline of 145.8±20.6 nl O2/cm3·s. 
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Figure 11.  Transient PISFO2 data for 5 seconds of ischemia.  Data presented as Means ± SEM 
with n=15. 
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Figure 12.  Normalized transient PISFO2 data for 5 seconds of ischemia.  Baseline 
PISFO2=65.8±4.2 mmHg.  Data presented as Means ± SEM with n=15. 
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Figure 13.  Flow data for 5 seconds of ischemia.  Data presented as Means ± SEM with n=12. 
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Figure 14.  Normalized flow data for 5 seconds of ischemia.  Baseline flow=6.00±0.74 µl/min.  
Data presented as Means ± SEM with n=12. 
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Figure 15.  Oxygen consumption data for 5 seconds of ischemia.  Data presented as Means ± 
SEM with n=12.  I represents start of ischemia; R represents start of reperfusion.   
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Figure 16.  Normalized oxygen consumption data for 5 seconds of ischemia.  Baseline 
VO2=145.8±20.6 nl O2/cm3·s.  Data presented as Means ± SEM with n=12.  I represents start of 
ischemia; R represents start of reperfusion. 
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15-second Ischemia 
Transient PISFO2 study 
The average data described in Fig. 17 demonstrate that following fifteen seconds of ischemia, the 
interstitial oxygen tension went from an average baseline of 61.9±3.7 mmHg to 34% (Fig. 18) or 
21.0±2.8 mmHg before returning to baseline within fifteen seconds. 
 
Flow study 
The average data described in Fig. 19 demonstrate that following fifteen seconds of flow 
stoppage, the blood flow increased up to 10% (Fig. 20) or 5.80±0.65 µl/min for the first 25 
seconds before returning to a baseline of 5.38±0.62 µl/min. 
 
VO2 study 
The average data described in Fig. 21 demonstrates that following fifteen seconds of ischemia, 
tissue oxygen consumption increased up to 122% or 136.5±20.1 nl O2/cm3·s for 20 seconds 
before returning to an average baseline of 124.6±18.5 nl O2/cm3·s. 
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Figure 17.  Transient PISFO2 data for 15 seconds of ischemia.  Data presented as Means ± SEM 
with n=16. 
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Figure 18.  Normalized transient PISFO2 data for 15 seconds of ischemia.  Baseline 
PISFO2=61.9±3.7 mmHg.  Data presented as Means ± SEM with n=16. 
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Figure 19.  Flow data for 15 seconds of ischemia.  Data presented as Means ± SEM with n=12. 
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Figure 20.  Normalized flow data for 15 seconds of Ischemia.  Baseline blood flow=5.38±0.62 
µl/min .  Data presented as Means ± SEM with n=12. 
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Figure 21.  Oxygen consumption data for 15 seconds of ischemia.  Data presented as Means ± 
SEM with n=12.  I represents start of ischemia; R represents start of reperfusion. 
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Figure 22.  Normalized oxygen consumption data for 15 seconds of ischemia.  Baseline 
VO2=124.6±18.5 nl O2/cm3·s.  Data presented as Means ± SEM with n=12.  I represents start of 
ischemia; R represents start of reperfusion. 
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30-second Ischemia 
Transient PISFO2 study 
The average data described in Fig. 23 demonstrates that following thirty seconds of ischemia, the 
oxygen tension went from an average baseline of 63.5±3.8 mmHg to 10% (Fig. 24) or 5.8±1.2 
mmHg before returning to baseline within thirty seconds. 
 
Flow study 
The average data described in Figs. 25 and 26 demonstrate that following thirty seconds of flow 
stoppage, the blood flow came back to a baseline of 6.10±0.92 µl/min within eleven seconds. 
 
VO2 study 
The average data described in Fig. 27 demonstrate that following thirty seconds of ischemia, 
tissue oxygen consumption increased up to 141% (Fig. 28) or 134.2±19.0 nl O2/cm3·s and within 
twenty seconds returned to an average baseline of 97.6±13.5 nl O2/cm3·s. 
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Figure 23.  Transient PISFO2 data for 30 seconds of ischemia.  Data presented as Means ± SEM 
with n=16. 
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Figure 24.  Normalized transient PISFO2 data for 30 seconds of ischemia.  Baseline 
PISFO2=63.5±3.8 mmHg.  Data presented as Means ± SEM with n=16. 
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Figure 25.  Flow data for 30 seconds of ischemia.  Data presented as Means ± SEM with n=12. 
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Figure 26.  Normalized flow data for 30 seconds of ischemia.  Baseline blood flow=6.10±0.92 
µl/min.  Data presented as Means ± SEM with n=12. 
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Figure 27.  Oxygen consumption data for 30 seconds of ischemia.  Data presented as Means ± 
SEM with n=12.  I represents start of ischemia; R represents start of reperfusion. 
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Figure 28.  Normalized oxygen consumption data for 30 seconds of ischemia.  Baseline 
VO2=97.6±13.5 nl O2/cm3·s.  Data presented as Means ± SEM with n=12.  I represents start of 
ischemia; R represents start of reperfusion. 
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60-second Ischemia 
Transient PISFO2 study 
The average data described in Fig. 29 demonstrate that following sixty seconds of ischemia, the 
oxygen tension went from an average baseline of 58.5±3.8 mmHg to 2% (Fig. 30) or 1.5±0.2 
mmHg before returning to baseline within sixty seconds. 
 
Flow study 
The average data described in Figs. 31 and 32 demonstrate that following sixty seconds of flow 
stoppage, the blood flow came back to a baseline of 5.78±0.84 µl/min within seven seconds. 
 
VO2 study 
The average data described in Fig. 33 demonstrate that following sixty seconds of ischemia, 
tissue oxygen consumption increased up to 125% (Fig. 34) or 145.7±23.0 nl O2/cm3·s and within 
sixty seconds return to an average baseline of 110.4±16.4 nl O2/cm3·s. 
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Figure 29.  Transient PISFO2 data for 60 seconds of ischemia.  Data presented as Means ± SEM 
with n=15. 
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Figure 30.  Normalized transient PISFO2 data for 60 seconds of ischemia.  Baseline 
PISFO2=58.5±3.8 mmHg.  Data presented as Means ± SEM with n=15. 
  
 68 
0 10 20 30 90 120 150 180 210 240 270
-1
0
1
2
3
4
5
6
7
8
Fl
ow
 (µ
l/m
in
)
Time (sec)  
Figure 31.  Flow data for 60 seconds of ischemia.  Data presented as Means ± SEM with n=12. 
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Figure 32.  Normalized flow data for 60 seconds of ischemia.  Baseline flow=5.78±0.84 µl/min.  
Data presented as Means ± SEM with n=12. 
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Figure 33.  Oxygen consumption data for 60 seconds of ischemia.  Data presented as Means ± 
SEM with n=12.  I represents start of ischemia; R represents start of reperfusion. 
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Figure 34.  Normalized oxygen consumption data for 60 seconds of ischemia.  Baseline 
VO2=110.4±16.4 nl O2/cm3·s.  Data presented as Means ± SEM with n=12.  I represents start of 
ischemia; R represents start of reperfusion. 
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300-second Ischemia 
Transient PISFO2 study 
The average data described in Fig. 35 demonstrate that after reaching 2% of its baseline 
following 300 seconds of ischemia, the oxygen tension returned to an average baseline of 
62.9±3.9 mmHg (Fig. 36) within 250 seconds.   
 
Flow study 
The average data described in Figs. 37 and 38 demonstrates that following 300 seconds of flow 
stoppage, the blood flow came back to an average baseline of 4.8±1.6 µl/min within thirty 
seconds. 
 
VO2 study 
The average data described in Fig. 39 demonstrates that following 300 seconds of ischemia, 
tissue oxygen consumption increased up to 190% (Fig. 40) or 294.8±48.1 nl O2/cm3·s and within 
80 seconds returned to an average baseline of 176.1±35.5 nl O2/cm3·s. 
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Figure 35.  Transient PISFO2 data for 300 seconds of ischemia.  Data presented as Means ± SEM 
with n=10. 
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Figure 36.  Normalized transient PISFO2 data for 300 seconds of ischemia.  Baseline 
PISFO2=62.9±3.9 mmHg.  Data presented as Means ± SEM with n=10. 
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Figure 37.  Flow data for 300 seconds of ischemia.  Data presented as Means ± SEM with n=8. 
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Figure 38.  Normalized flow data for 300 seconds of ischemia.  Baseline flow=4.8±1.6 µl/min.  
Data presented as Means ± SEM with n=8. 
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Figure 39.  Oxygen consumption data for 300 seconds of ischemia.  Data presented as Means ± 
SEM with n=8.  I represents start of ischemia; R represents start of reperfusion. 
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Figure 40.  Normalized oxygen consumption data for 300 seconds of ischemia.  Baseline 
VO2=176.1±35.5 nl O2/cm3·s.  Data presented as Means ± SEM with n=8.  I represents start of 
ischemia; R represents start of reperfusion. 
  
 79 
600-second Ischemia 
Transient PISFO2 study 
The average data described in Fig. 41 demonstrates that following 600 seconds of ischemia, the 
oxygen tension went from an average baseline of 58.6±7.61 mmHg to 3% or 1.3±0.4 mmHg 
(Fig. 42) and returned within 160 seconds. 
 
Flow study 
The average data described in Figs. 43 and 44 demonstrates that following 600 seconds of flow 
stoppage, the blood flow came back to a baseline of 4.35±0.42 µl/min within fifteen seconds. 
 
VO2 study 
The average data described in Fig. 45 demonstrates that following 600 seconds of ischemia, 
tissue oxygen consumption increased up to 254% (Fig. 46) or 309.2±45.0 nl O2/cm3·s and within 
120 seconds return to an average baseline of 147.4±67.2 nl O2/cm3·s.
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Figure 41.  Transient PISFO2 data for 600 seconds of ischemia.  Data presented as Means ± SEM 
with n=9. 
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Figure 42.  Normalized transient PISFO2 data for 600 seconds of ischemia.  Baseline 
PISFO2=58.6±7.6 mmHg.  Data presented as Means ± SEM with n=9. 
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Figure 43.  Flow data for 600 seconds of ischemia.  Data presented as Means ± SEM with n=8. 
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Figure 44.  Normalized flow data for 600 seconds of ischemia.  Baseline flow=4.35±0.42 
µl/min.  Data presented as Means ± SEM with n=8. 
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Figure 45.  Oxygen consumption data for 600 seconds of ischemia.  Data presented as Means ± 
SEM with n=8.  I represents start of ischemia; R represents start of reperfusion. 
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Figure 46.  Normalized oxygen consumption data for 600 seconds of ischemia.  Baseline 
VO2=147.4±67.2 nl O2/cm3·s.  Data presented as Means ± SEM with n=8.  I represents start of 
ischemia; R represents start of reperfusion. 
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Baseline Analysis 
A multivariate ANOVA demonstrated that the average baseline PISFO2 among the three studies 
and the six durations were not different (F=2.82, p=0.06).  There were no significant differences 
among the average baseline PISFO2 values of the Transient PISFO2, VO2, and flow studies 
(F=2.82, p=0.06); there were no significant differences among the average baseline PISFO2 values 
of the ischemic durations within each study (F=1.31, p=0.26); the same ischemic durations 
among the studies also demonstrated that there were no significant differences (F=0.33, p=0.97) 
in PISFO2.  Tukey-Kramer’s tests also demonstrated that there were no differences in the effect of 
ischemic duration or study on the PISFO2 (p >0.05).  A one way ANOVA performed on the 
baseline blood flow data during the Q study demonstrated that there was no significant difference 
among the baseline flow values of each ischemic duration (F=0.68, p=0.64).  Tukey’s HSD 
determined that there were no significant differences in average baseline flow values between 
any two ischemic groups.  A one way ANOVA performed on the baseline oxygen consumption 
data during the VO2 study demonstrated that there was no significant difference among the 
baseline consumption values of each ischemic duration (F=1.77, p=0.13).  Tukey’s HSD 
determined that there were no significant differences in baseline consumption values between 
any two ischemic groups. 
 
Baseline correlations to PISFO2: 
During the VO2 study, in addition to baseline PISFO2 data being collected, baseline VO2 data 
were collected as well.  To test whether there was a correlation between the two, oxygen 
consumption was plotted against the PISFO2 as shown in Fig. 47.  A regression slope test using 
Student’s t determined that the slope of the oxygen consumption as a function of the baseline 
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interstitial fluid PO2 was significant (p=0.006).  During the blood flow study, baseline flow 
measurements were plotted against the baseline PISFO2 measurements (Fig. 48) collected during 
the study to determine if there was a relationship between the two.  A regression slope test 
determined that the slope of the baseline blood flow as a function of the baseline PISFO2 was not 
significant (p=0.75). 
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Figure 47.  Baseline oxygen consumption versus baseline interstitial fluid PO2 during the VO2 
study (p=0.0596 <0.05). 
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Figure 48.  Baseline blood flow versus baseline interstitial fluid PO2 during the blood flow study 
(p=0.74742 >0.05). 
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Table 1.  Average baseline data for PISFO2, Q, VO2 studies and factor M; all data expressed as Means ± SEM.  Units: PO2 in mmHg, 
Q--µl/min, VO2--nl O2/cm3·s, M--nl O2/nl2·mmHg 
Parameter
Transient PO2 study data n Mean ±SEM n Mean ±SEM n Mean ±SEM n Mean ±SEM n Mean ±SEM n Mean ±SEM
Baseline PISFO2 15 65.78 4.23 16 61.89 3.73 16 63.49 3.75 15 58.50 3.84 10 62.92 3.87 9 58.60 7.62
Flow (Q) study data n Mean ±SEM n Mean ±SEM n Mean ±SEM n Mean ±SEM n Mean ±SEM n Mean ±SEM
Baseline Q 12 6.00 0.74 12 5.38 0.62 12 6.10 0.92 12 5.78 0.84 8 4.83 0.58 8 4.42 0.55
Baseline PArtO2 12 73.46 3.56 12 75.22 2.80 12 71.67 3.05 12 70.01 3.19 8 74.27 4.84 8 69.78 5.21
Baseline PISFO2 12 65.91 4.29 12 59.93 4.55 12 63.53 4.09 12 60.54 3.75 8 60.23 6.05 8 56.49 6.19
Baseline ѐPO2 12 7.71 1.45 12 13.63 3.29 12 10.67 2.16 12 11.80 2.17 8 14.04 2.65 8 13.29 2.76
Oxygen Consumption 
(VO2) study data n Mean ±SEM n Mean ±SEM n Mean ±SEM n Mean ±SEM n Mean ±SEM n Mean ±SEM
Baseline VO2 12 145.84 20.59 12 124.62 18.46 12 97.55 13.54 12 110.36 16.43 8 176.08 35.53 8 147.42 23.77
Baseline PArtO2 12 68.81 2.50 12 74.19 3.29 12 68.92 3.46 12 68.92 3.04 8 67.64 3.96 8 69.68 2.83
Baseline PISFO2 12 61.01 2.96 12 61.58 4.30 12 53.92 4.23 12 57.61 4.09 8 52.74 4.63 8 49.72 5.03
Baseline ѐPO2 12 7.80 1.31 12 12.61 1.89 12 14.99 2.55 12 11.30 1.86 8 14.89 2.54 8 19.96 4.50
M n Mean ±SEM n Mean ±SEM n Mean ±SEM n Mean ±SEM n Mean ±SEM n Mean ±SEM
From Q study data 12 5.53 1.34 12 4.23 1.44 12 2.96 0.66 12 5.52 2.70 8 3.38 0.54 8 3.35 0.62
From VO2 study data 12 5.44 1.51 12 2.21 0.37 12 1.52 0.35 12 2.36 0.54 8 2.94 0.79 8 3.08 1.34
5 sec
Ischemic Duration
600 sec300 sec60 sec30 sec15 sec
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Initial Recovery Rates during Reperfusion 
The initial rate of recovery for the three variables in each of the ischemic durations within each 
study was calculated from the PISFO2 data for the Transient PISFO2 and VO2 studies—Q could not 
be measured simultaneously.  Only the initial rate of flow recovery was calculated for the Q 
studies since PO2 could not be recorded simultaneously. 
 
Transient PISFO2 
The average initial rate of recover of PISFO2 (Fig. 49) for 5 seconds of ischemia was 0.84±0.12 
mmHg/s, 3.09±0.36 mmHg/s for 15 seconds, 4.25±0.72 mmHg/s for 30 seconds, 3.25±0.42 
mmHg/s for 60 seconds, 2.95±0.49 mmHg/s for 300 seconds and 1.00±0.16 mmHg/s for 600 
seconds of ischemia.  A one-way ANOVA demonstrated that the initial rates of recovery among 
the ischemic durations were significantly different (F=15.19, p=3.92·10-10).  The initial rates of 
reperfusion during 5 seconds of ischemia were significantly different than 15, 30, 60 and 300 
seconds of ischemia (p <0.05).  The initial rates of recovery following 600 seconds of ischemia 
were significantly different from the rates during 30 and 300 seconds of ischemia. 
 
Blood Flow 
The average initial rate of recovery of flow during the blood flow study (Fig. 50) for 5 seconds 
of ischemia was 3.00±0.32 (µl·min-1)/s, 3.91±0.52 (µl·min-1)/s for 15 seconds, 4.91±0.45 
(µl·min-1)/s for 30 seconds, 7.04±0.55 (µl·min-1)/s for 60 seconds, 2.83±0.55 (µl·min-1)/s for 300 
seconds and 2.92±0.45 (µl·min-1)/s for 600 seconds of ischemia.  A one-way ANOVA 
demonstrated that the initial rates of blood flow recovery during reperfusion among the ischemic 
durations were significantly different (F=12.02, p=5.30·10-8).  The initial rate of blood flow 
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recovery following 5 seconds of ischemia was significantly different from that of the 30 and 60 
second ischemia groups (p <0.05).  The initial rate of blood flow following 60 seconds of 
ischemia was significantly different from that of the 15-, 300- and 600-second groups (p <0.05). 
 
Recovery of PISFO2 in VO2 study 
The average initial rate of reperfusion of the PISFO2 in the interstitial space during the oxygen 
consumption study (Fig. 51) for 5 seconds of ischemia was 0.82±0.13 mmHg/s, 4.18±0.69 
mmHg/s for 15 seconds, 6.23±0.68 mmHg/s for 30 seconds, 7.45±0.83 mmHg/s for 60 seconds, 
3.09±0.41 mmHg/s for 300 seconds and 1.05±0.33 mmHg/s for 600 seconds of ischemia.  A one-
way ANOVA demonstrated that the initial rates of recovery among the ischemic durations were 
significantly different (F=21.40, p=2.73·10-11).  The initial rates of recovery following 5 seconds 
of ischemia were significantly different from those for 15, 30, 60 and 300 seconds of ischemia (p 
<0.05).  The initial rates of reperfusion during 600 seconds of ischemia were significantly 
different than the rates during 15, 30 and 60 seconds of ischemia (p <0.05). 
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Figure 49.  Initial rates of recovery of PISFO2 during reperfusion of the Transient PISFO2 
(PO2 <20 mmHg) study.  Data presented as Means ± SEM.  *Significance: Letter and/or color 
pairs indicate that two groups they are above are significantly (p <0.05) different; i.e.,  
AA—5- and 300-second ischemic durations have significantly (p <0.05) different initial recovery 
rates.  
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Figure 50.  Initial rate of recovery of flow during reperfusion of the Blood Flow study.  Data 
presented as Means ± SEM.  *Significance: Letter and/or color pairs indicate that two groups 
they are above are significantly (p <0.05) different; i.e., AA—5- and 30-second ischemic 
durations have significantly (p <0.05) different initial recovery rates.  
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Figure 51.  Initial rate of recovery of PISFO2 (<20 mmHg) during reperfusion of the Oxygen 
Consumption study.  Data presented as Means ± SEM.  *Significance: Letter and/or color pairs 
indicate that two groups they are above are significantly (p <0.05) different; i.e., AA—5- and 60-
second ischemic durations have significantly (p <0.05) different initial recovery rates. 
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Percent increase in VO2 during reperfusion 
A one-way ANOVA and Tukey’s HSD on the post-ischemia phase of the oxygen consumption 
study demonstrated that there significant differences in the consumptions between the groups 
(F=9.61, p=1.02·10-6).  The earliest measurement of oxygen consumption during reperfusion 
following 300 seconds of ischemia (Fig. 52) was significantly higher (up to 294.8±48.1 nl 
O2/cm3·s) than that for 5, 15, 30 and 60 seconds of ischemia (p <0.05).  Oxygen consumption 
during 600 seconds of ischemia (Fig. 52) was also significantly higher (up to 309.2±45.1 nl 
O2/cm3·s) than the same group of durations but there was no statistically significant difference 
between the oxygen consumptions of the 300 and 600 second ischemia groups.
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Figure 52.  Percent of VO2 baseline at the earliest measurement of reperfusion.  30 sec ischemia, 
60 sec ischemia, 300 sec ischemia, 600 sec ischemia delayed by 3, 5, 20 and 20 seconds 
respectively from the start of reperfusion.  Data presented as Means ± SEM.  *Significantly 
different from 5-60 seconds of ischemia groups (p <0.05). 
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Relating VO2, Q and PISFO2 with the factor, M 
The factor M was calculated for the baseline values of the oxygen consumption and blood flow 
data using Equation 30.  The average value for M during the baseline of the blood flow study 
was 2.72±1.31 nl O2/nl2·mmHg.  For the oxygen consumption study, the average value of M was 
2.15±1.16 nl O2/nl2·mmHg.  This demonstrated a relatively constant relationship between 
oxygen consumption and blood flow during the baseline period. 
 
Since the VO2 data limited how much of the duration could be characterized by M, 
corresponding normalized values from the VO2 and Q studies at the same point in each 
experiment and ischemic duration were combined and plotted as a function of time.  The 
Transient PISFO2 study did not have PaO2 available so the information for ¨PO2 was taken and 
normalized using the PISFO2 and PaO2 data from the VO2 study.  This allowed two variables to 
come from the exact same site, animal, and study.   Flow data was added from the Blood Flow 
study.  The errors of each of the variables obtained was propagated and M was computed. 
 
Figs. 53 & 54 report the factor M collected for 5-, 15-, 30-, 60-, 300- and 600-second ischemia 
groups.  Since the data was normalized to the baseline, all points graphed began at 1.0.  The 5-60 
second groups noticeably recovered to baseline within 180 seconds while the 300- and 600-
second ischemia groups demonstrated large changes during that time.  5 seconds of ischemia 
demonstrated a slower decline back to the baseline but enough data points were not collected to 
observe it over a longer stretch of time.  300 seconds of ischemia demonstrated the most change 
from the baseline and did not recover in the same manner and rate as the 600-second ischemia 
group. 
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Figure 53.  Factor M calculated for 5-, 15-, 30- and 60-second ischemia groups using the 
normalized data.  Data presented as Means ± SEM.   
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Figure 54.  Factor M Factor M calculated for the 300- and 600-second ischemia group using the 
normalized data.  Data presented as Means ± SEM.  
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Discussion 
The Transient PISFO2 study demonstrated that although there wasn’t a significant increase 
in interstitial oxygen tension at the onset of reperfusion, the time course over which the PISFO2 
returned to baseline increased as the ischemic duration increased.  This occurred over fifteen 
seconds for 5 seconds of ischemia to 250 seconds for 300 seconds of ischemia.  The blood flow 
study data collected has demonstrated a similar pattern to the Transient PISFO2 in that as the 
ischemic duration increased, the time course over which the flow returned to baseline following 
ischemia increased.  However, just as it was with the Transient PISFO2 study, the 300sec-
ischemic group had a much longer time course (30 seconds) than the 600-second ischemia group 
(15 second time course) over which the blood flow recovered to baseline.  VO2 data indicated 
that peak oxygen consumption increased as a direct result of the ischemic duration.  VO2 peaked 
at 309.2±45.0 nl O2/cm3·s or 254% of its baseline and recovered within 120 seconds.  As the 
ischemic duration increased, the time course over which the VO2 recovered following ischemia 
also increased and ranged from 20 seconds following the 15-second ischemia group to 120 
seconds following the 600-second ischemia group.  The VO2 and Q data was then incorporated 
into finding an approximation for the factor M as a function of time in each site of every 
ischemic duration. 
Blood flow in the cardiovascular system and microcirculation is tightly regulated to 
ensure that an adequate oxygen supply is available to respiring tissue as needed.  When this 
balance in supply and demand is interrupted at a global level—through increased oxygen 
consumption by the tissue or decreased blood supply—regulatory mechanisms act by increasing 
ventilation, heart rate, stroke volume, sympathetic activity and circulating concentrations of 
vasoactive hormones.  Although these systemic effects will act to ensure that the supply of 
 102 
oxygen to the tissue at any given time is increased to the appropriate level, the microcirculation 
and mechanisms which control local blood flow will ultimately determine whether the tissue 
receives what it needs. 
This study attempted to establish a relationship between three intrinsic characteristics of 
the local regulation of tissue oxygenation: flow of oxygenated blood (QO2), the oxygenation of 
the tissue as reported by PISFO2, as well as the rate of oxygen consumption by the tissue (VO2).  
It should be noted that, although this work helps to understand how these variables are related to 
one another, the results themselves cannot explain the mechanism(s) by which local blood flow 
and tissue oxygenation are regulated.  Rather, by defining the limits of change in one parameter 
with respect to the other two, any proposed mechanism can be tested and, if the results deviate 
significantly from the defined limits, it can be reasoned that an alternative mechanism should be 
considered or that there are additional variables at work. 
Due to technical design limitations, the three variables were observed in independent 
studies: the Transient PISFO2, Oxygen Consumption (VO2) and Blood Flow (Q) studies.  Since 
that was the case, PISFO2 measurements were made during the baseline at each site in each study 
to be used later as the basis for comparison among the studies.  If the values were statistically 
similar, then it could be assumed that the values found during the studies originated from similar 
starting conditions; despite having site-to-site and animal-to-animal heterogeneity. 
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The Baselines 
Baseline measurements at each site were made for a period of 30 to 60 seconds (for VO2 
study) prior to the onset of ischemia and reperfusion and, as such, should have been similar 
throughout all of the experiments.  A comparison of the baseline PISFO2 measurements for each 
ischemic duration averaged to 62.1±1.7 mmHg during the transient study and showed that there 
were no significant differences in these measurements (F=0.43, p=0.83), supporting the idea that, 
although the protocols were performed in succession, one did not affect the other—ostensibly 
making each measurement independent.  In other words, each experiment can be considered 
independently of the one before it, despite having been done in succession, and any differences 
in the reperfusion phase cannot be attributed to differences in the baseline PISFO2.  The same 
significance testing was done on the data collected from the VO2 and Q studies which yielded the 
same results—no significant differences were demonstrated among the baseline VO2 
measurements, which averaged 130.1±8.7 nl O2/cm3·s; and no significant differences were found 
among the baseline Q measurements, which averaged 5.52±0.31 µl/min. 
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Transient Interstitial Fluid O2 Tension, PISFO2 
It was observed in the Transient PISFO2 study that, as the ischemic duration increased, the 
initial rate of PISFO2 recovery increased.  The rate of recovery during 5 seconds of ischemia was 
significantly lower (p<0.05) than the rates during the 15 to 300 second ischemic durations.  As 
the ischemic duration increased in steps to 30 seconds, the rate of recovery significantly 
increased from 0.84±0.12 mmHg/s for the 5-second group to 4.25±0.72 mmHg/s for the 30–
second group.  However, as shown in Fig. 47, when the ischemic duration went beyond 30 
seconds of ischemia, the initial rate of PISFO2 recovery began to diminish until it reached a point 
close to that found for the 5-second ischemic duration group.  This recovery rate went from a 
maximum 4.25±0.72 mmHg/s at 30 seconds of ischemia to 1.00±0.16 mmHg/s for 600 seconds 
of ischemia. 
Previous studies in myocardial tissue (Cai et al., 2011) related blood flow and tissue 
oxygenation in ischemic preconditioning and demonstrated that, as ischemic durations increased, 
the initial rate of tissue PO2 recovery decreased.  The present study shows that for brief (<30 sec) 
durations of ischemia, the initial rate of recovery increased until a limit was reached after which 
the initial rate began to decline as the ischemic duration increased.  A possible reason for this is 
that, during the prolonged ischemic phase, mitochondrial activity was impaired and when blood 
flow returned, reactive metabolites (e.g., O2---superoxide radical, H2O2--hydrogen peroxide, 
ONOO---peroxynitrite, cyclooxygenases, xanthine oxidase, NADH/NADPH) diffused to nearby 
parts of the tissue to further damage them.  It could also be that prolonged ischemia prevented a 
high enough PO2 gradient from being established between the tissue and the blood supply and, as 
a result, the rate at which oxygen diffused to the interstitium decreased.  The PISFO2 being able to 
return to baseline quickly during the shorter ischemic durations (5-60 seconds of ischemia) could 
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be attributed to myogenic effects in which slight hyperemic effects that caused an increase in the 
rate of recovery were immediately attenuated. 
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Blood Flow, Q 
Numerous studies have been conducted to try and understand the mechanism by which 
changes in blood flow occur following ischemia/reperfusion.  An earlier study conducted to 
determine the effect of occlusion duration on reactive hyperemia (Johnson et al., 1976) observed 
that a graded increase in the duration of vessel occlusion caused a graded increase in blood flow.  
Peak blood flow reached 280% above baseline following 120 seconds of occlusion in venous 
outflow.  It was also observed that brief ischemic periods caused large (200%) increases in 
capillary flow.  Data from the present blood flow study demonstrated that, although blood flow 
did not noticeably increase above the baseline following ischemia, the rate at which the flow 
recovered (Fig. 50) significantly increased following 5 seconds of ischemia where it was 
2.99±0.32 (µl·min-1)/s to 60 seconds of ischemia where it was 7.04±0.55 (µl·min-1)/s (p<0.05).  
However, for ischemic durations greater than 60 seconds, the rate at which blood flow recovered 
significantly dropped.  Following 300 seconds of ischemia, the rate significantly dropped to 
2.83±0.55 (µl·min-1)/s from 7.04±0.55 (µl·min-1)/s following 60 seconds, but increased to 
2.92±0.45 (µl·min-1)/s following 600 seconds of ischemia. 
In addition to the initiation of pro-inflammatory cascades at the onset of reperfusion, a 
secondary point of ischemic damage has been observed after the return of flow to baseline 
(Reffelmann et al., 2003).  The no-reflow phenomenon (Menger et al., 1992) describes the 
failure of capillary perfusion that occurs once flow has returned in the larger vessels following 
ischemia.  A number of reasons for this failure have been suggested:  obstructions by clot 
formations, leukocyte plugging, endothelial cell swelling, increase in blood viscosity and 
increase in hydraulic resistance (Benz et al., 2002).  The no-reflow phenomenon could 
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potentially be a cause of the significant decrease observed in the rate of recovery of flow during 
the reperfusion phase following 300 and 600 seconds of ischemia. 
The same idea can also be applied to the delay in PISFO2 recovery.  Although oxygen 
tension eventually returned to baseline, at least during the time course we observed, the rate at 
which it recovered was significantly different among the ischemic durations tested.  Despite a 
lack of significant differences in PISFO2 between 300 and 600 second ischemic durations, there 
were significant differences in the rate at which the PISFO2 recovered (p <0.05) between the two.  
This goes to suggest that, by prolonging the ischemic duration past the observed critical point of 
30 seconds, a progressive increase in capillary perfusion failure causes the rate at which the 
oxygen-deprived tissue is replenished to decrease.  In addition to that, certain changes occur by 
300 seconds of ischemia that cause the rate at which the flow recovers to also significantly 
decrease—due in part to possibly any of the reasons previously mentioned that could prevent 
flow following the cessation of ischemia. 
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Oxygen Consumption, VO2 
By utilizing a novel quasi-continuous approach (5-sec flow stoppage/15-sec flow 
recovery) to observe dPO2/dt using the PQM and ischemia/reperfusion system, VO2 
measurements were made for each of the ischemic durations established in the protocol.  With 
some minor adjustments to the time when baseline started and when reperfusion observations 
ended, more data points could be collected as the system is designed to only acquire one 
measurement every 20 seconds.  Oxygen consumption measurements were delayed until PISFO2 
reached >20 mmHg, because it is at this critical point where oxygen consumption becomes 
dependent on PO2.  Based on the oxygen dissociation curve, the quasi-linear range of PO2 (20-40 
mmHg) was used to approximate the oxygen saturation, SO2 (Eq. 20), as a function of the slope 
of the region, the hemoglobin concentration, the O2-carrying capacity of Hb, and the oxygen 
tension.  For the model to be able to express the variables in terms of linear changes, the linear 
portion of the oxygen dissociation curve was used.  If measurements were to be taken below 20 
mmHg, oxygen consumption and the values obtained for it would become dependent on PO2. 
The average baseline VO2 of 130.1±8.7 nl O2/cm3·s in resting skeletal muscle was 
consistent with what has been observed in previous work from this laboratory (Golub et al., 
2011b), confirming the use of the technique in the present experiments.  The observed pattern of 
oxygen consumption by the tissue following ischemia; as shown in Figs. 27, 28, 33, 34, 39, 45 
and 46; behaved similarly to exercise and fatigue studies performed in human muscle tissue 
using near-infrared (NIR) diffuse optical methods (Gurley et al., 2012).  It should be noted that 
Gurley et al. reported values of 20 nl O2/cm3·s, but the protocol and time course over which their 
data were collected is similar to that of the present study. 
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Peak oxygen consumption of 309.2±45.0 nl O2/cm3·s occurred at the first measurement 
taken following 600 seconds of ischemia.  Since the tissue was deprived of oxygen for such an 
extended period of time, it would stand to reason that the time course over which the VO2 values 
recovered to baseline during reperfusion would be longer than for shorter ischemic durations.  
For 600 seconds of ischemia VO2 returned to baseline within 160 seconds.  The time course for 
recovery progressively decreased as the ischemic duration became smaller, such that it returned 
to baseline within 15 seconds during 5 seconds of ischemia—this also helped establish the use of 
the quasi-continuous VO2 measurement system, because very little change occurred in the VO2 
measurements during that part of the study.  When observing the normalized VO2 data from the 
start of reperfusion and on, the 300- and 600-second groups presented themselves as being 
significantly higher (p <0.05) than results from the 5-, 15-, 30- and 60-second ischemia groups, 
however they were not different from one another (p=0.3665). 
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Factor M 
With perivascular (PaO2) and interstitial (PISFO2) oxygen tensions collected during the 
baseline of the VO2 and Q studies, these two sets of data could be compared to one another using 
the factor M (Eq. 30).  M simultaneously relates the three key variables of tissue oxygenation 
and blood flow regulation:  VO2, Q and ¨PO2, where ¨PO2 is the difference between the 
arteriolar (PaO2) and interstitial (PISFO2) oxygen tensions: 
ܯ = ሶܸைమ
ܳ ή ο ைܲమ
 
By knowing how M behaves, the behavior of ߚ[ܪܾ] ή (ͳ െ ݁ି௭) from Eq. 29 can be observed.  
Under steady-state conditions, each of the variables that compose M should remain relatively 
constant, making M constant.  The value of M might also remain relatively constant during the 
transient recovery phase of post-ischemia reperfusion, if those variables are regulated by the 
same mechanism(s), but the values that compose it would not be expected to remain constant.  At 
the start of ischemia, all variables are at their respective baseline levels, and the ratio M should 
remain relatively constant for all baseline periods. 
Since PaO2 data were not collected for the Transient PISFO2 study, data collected from the 
VO2 study was used in its place.  With PaO2 and PISFO2 data available for every site in the VO2 
study, baseline ¨PO2 values were determined and used in the calculation of M.  With PaO2 data 
unavailable through the duration of the experiment from the start of ischemia, it was assumed 
that the PaO2 values remained relatively constant (Assumption #1) throughout the experiment.  
Only the PISFO2 values should change as the supply and consumption balance changed over time 
during recovery and, with that, the data through the start of reperfusion (or when the first 
consumption measurement is taken) were normalized to the baseline values.  Since the VO2 was 
the limiting variable on account of only having been collected every 20 seconds, normalized 
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flow values were taken from the corresponding time points at which the consumption 
measurements were made.  With normalized ¨PO2, Q and VO2 data from every site within a 
particular ischemic duration, a normalized factor M can be calculated on a site-to-site basis for 
all six ischemic duration groups with respect to time. 
Figures 53 and 54 show the results of the calculations for M.  The recovery period of M 
for the smaller ischemic durations (5 through 60 seconds) was much shorter than it was for the 
longer ischemic durations.  With much variability present within the calculations and a 
significant increase of M 60 seconds into the recovery period of the 300- and 600-second 
ischemia groups, the most important conclusion that can be drawn from this is that site-to-site 
variability may play a bigger role than what was originally anticipated.  It is also apparent that, 
despite the ischemic duration, the value of M always returned to baseline with only the 300-
second group deviating from this pattern by not fully recovering during the observation time.  If 
the consequences of the no-reflow phenomenon were going to appear, it would most certainly 
appear first in the 600-second group and then, depending on the degree of change to the vascular 
network, to the shorter durations.  The 5- through 60-second ischemic duration groups did not 
display drastic changes and the changes of the 600-second group in relation to the 300-second 
ischemia group were attenuated.  This behavior led to the conclusion that the experiments for the 
300-second ischemic group need to be repeated, to observe if this kind of behavior is consistent 
or specific for that set of data.  If that is the case, they will need to be approached with a different 
modeling strategy. 
ߚ and [ܪܾ] are physiological parameters that should remain relatively constant through 
the duration of the experiment.  In this case, any changes in the factor M represent changes in the 
factor “z” since z is a function of the flow.  If it can be determined that M remains reasonably 
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constant through the baseline and transient recovery period before approaching a new steady 
state, then it can be assumed that z is also a constant.  If it is the case that z only changes with 
respect to the ischemic duration, then a model that relates the three variables with respect to the 
ischemic duration (or function of time) can be obtained. 
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Extensions of the Work 
Although not a focus of this study, it is interesting to note that recent work (Casey et al., 
2011) has indicated that following hypoxia, compensatory vasodilation occurs in which the 
imbalances in oxygen supply and demand are dealt with by temporarily increasing blood flow to 
increase the oxygen delivery.  This has been a topic of much debate among researchers in 
microcirculation and hemodynamics for many years, but recently efforts have been made to 
understand the role that nitric oxide (NO) plays in the regulatory system.  That has become the 
topic of much of the work in which this laboratory is currently engaged (Golub & Pittman, 2013) 
and a focus for future projects.  The work from this study, in conjunction with experimental 
evidence for a NO-mediated compensatory mechanism, can help establish the causal relationship 
between NO and the regulation of local blood flow. 
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Future Studies 
The next step in these studies will be to determine how z is influenced by blood flow and 
the geometry of the vessel.  Although it is not expected that the geometry should permanently 
change, it will still be necessary to empirically demonstrate this.  Since the 5-second ischemic 
duration has not made a substantive contribution in supporting the compartmental model, it will 
be removed from future experiments.  The data collected so far have confirmed that the quasi-
continuous VO2-sampling technique can effectively determine oxygen consumption.  In terms of 
the protocol itself, no changes will be made, however, instead of looking at multiple durations at 
a single site, only one ischemic duration will be used at multiple sites.  This will allow efficient 
sampling of VO2, PaO2, PISFO2 and Q to be done within a reasonable amount of time.  By doing 
this, any site-to-site heterogeneity will be eliminated because all the data necessary information 
will be contemporaneously recorded.  It will also no longer be necessary to relate variables 
obtained under dissimilar conditions.  Since changes in recovery were seen in the blood flow 
study for extended periods of ischemia, it may prove beneficial to designate experiments in 
which observations of leukocyte adhesion in microvenules are made, as well as any changes in 
capillary perfusion—enough so to affect an entire site.   
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Conclusions 
The data presented here have been of novel work that has never incorporated so many 
different, non-invasive, non-destructive techniques in an attempt to understand and define the 
limits of how tissue oxygenation, consumption, and blood supply are regulated.  These data were 
obtained systematically in an attempt to determine how skeletal muscle tissue responds to 
varying ischemic durations.  Never before have the rates of reperfusion been determined which 
distinctly outline how the tissue is expected to recover over a certain period of time.  By using 
velocity information that has been corrected to account for geometric changes of the vessel being 
observed, a novel, quasi-continuous system to measure oxygen consumption, and a highly 
reliable and well-respected method of determining oxygen partial pressures, strong empirical 
evidence has been collected for characterizing the relationships among oxygen consumption, 
blood supply, and tissue oxygenation. 
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